The Recall Desk
ModerateFDA (Drugs)·D-1624-2020·Announced 2020-09-30

Preferred Pharmaceuticals Recalls Nature-Throid Tablets Due to Manufacturing Deviations

Preferred Pharmaceuticals is voluntarily recalling Nature-Throid tablets due to CGMP deviations. The affected repackaged tablets were sold to three physicians in California and Georgia.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and is voluntary, initiated due to CGMP deviations without reported illnesses or injuries, fitting the criteria for a moderate severity score.

Plain-English summary

Preferred Pharmaceuticals, Inc. is voluntarily recalling Nature-Throid, 1.5 Grain tablets (NDC 68788-7605-09). The recall was initiated on September 2, 2020, and was classified as Class II by the FDA. The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations.

The affected product consists of 90-count bottles of repackaged tablets manufactured by RLC Labs in Cave Creek, Arizona. The specific lot involved is A0220R, with an expiration date of February 28, 2021. The tablets contain Thyroid U.S.P. 1.5 gr. (97.5mg), Liothyronine (T3) 13.5mcg, and Levothyroxine (T4) 57mcg.

Distribution was limited to three physicians located in California and Georgia. The recall was initiated by the firm and notified via letter. The recall status is currently terminated.

The recalled product

Product
Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg, 90-count bottles, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-7605-09
Manufacturer
Preferred Pharmaceuticals, Inc.
Category
Drug — Thyroid Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • a) Lot #: A0220R
  • Exp. Date: 2/28/2021

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 4 recalled by Preferred Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Related recalls

Same manufacturer · Preferred Pharmaceuticals, Inc.

See all →

Same hazard · cgmp deviations

See all →